CRP and psoriasis: Based on the present results, when deciding the type of TNF-α inhibitors to treat psoriasis patients, ADA might be applicable to patients with scalp lesions and/or higher baseline PASI scores; CZP might be applicable to patients with a lower baseline CRP; IFX might be applicable to patients without genital lesions.